Maddrey WC: Hepatitis B: an important public health issue. J Med Virol 2000, 61: 362-366. 10.1002/1096-9071(200007)61:3<362::AID-JMV14>3.0.CO;2-I
Article
CAS
PubMed
Google Scholar
Lee WM: Hepatitis B virus infection. N Engl J Med 1997, 337: 1733-1745. 10.1056/NEJM199712113372406
Article
CAS
PubMed
Google Scholar
Lok AS, Heathcote EJ, Hoofnagle JH: Management of hepatitis B: 2000 – summary of a workshop. Gastroenterology 2001, 120: 1828-1853.
Article
CAS
PubMed
Google Scholar
Lok ASF, McMahon BJ: Chronic hepatitis B. Hepatology 2001, 34: 1225-1241. 10.1053/jhep.2001.29401
Article
CAS
PubMed
Google Scholar
Seegar C, Mason WS: Hepattits B virus: the major etiology of hepatocellular carcinoma. Cancer 1988, 61: 9142-56.
Google Scholar
Margolis HS, Alter MJ, Hadier SC: Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 1991, 11: 84-92.
Article
CAS
PubMed
Google Scholar
Beasley RP, Hwang LY, Lee GC, et al.: Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, 2: 1099-1102. 10.1016/S0140-6736(83)90624-4
Article
CAS
PubMed
Google Scholar
Lee WM: Hepatitis B virus infection. N Engl J Med 1997, 337: 1733-1745. 10.1056/NEJM199712113372406
Article
CAS
PubMed
Google Scholar
McQuillan GM, Townsend TR, Fields HA, Carrol M, Leahy M, Polk BF: Seroepidemiology of hepatitis B virus infection in the United States. Am J Med 1989,87(suppl 3A):5S-10S. 10.1016/0002-9343(89)90523-8
Article
CAS
PubMed
Google Scholar
CDC Immunization Practices Advisory Committee (ACIP): Hepatitis B Virus: A comprehensive strategy for limiting transmission in the United States through universal childhood vaccination. MMWR Morb Mortal Wkly Rep 1991,40(RR-13):1-25.
Google Scholar
Milich DR, Chen MK, Hughes JL, Jones JE: The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998, 160: 2013-2021.
CAS
PubMed
Google Scholar
Chemin I, Zoulim F, Merle P, et al.: High incidence of hepatitis B infections among chronic hepatitis cases of unknwon aetiology. J Hepatol 2001, 34: 471-473. 10.1016/S0168-8278(00)00100-8
Google Scholar
Kawatani T, Suou T, Tajima F, et al.: Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol 2001, 67: 45-50. 10.1034/j.1600-0609.2001.067001045.x
Article
CAS
PubMed
Google Scholar
Burk RD, Hwang LY, Ho GYF, Shafritz DA, Beasley RP: Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994, 170: 1418-1423.
Article
CAS
PubMed
Google Scholar
Cacciola I, Cerenzia G, Pollicino T, et al.: Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002, 36: 426-432. 10.1016/S0168-8278(01)00295-1
Article
CAS
PubMed
Google Scholar
Hoofnagle JH, Dusheiko GM, Seef LB, et al.: Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981, 94: 744-748.
Article
CAS
PubMed
Google Scholar
Fattovich G, Rugge M, Brollo L, et al.: Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986, 6: 167-172.
Article
CAS
PubMed
Google Scholar
Moreno-Otero R, Garcia-Monzòn C, Garcia-Sànchez A, et al.: Development of cirrhosis after chronic type B hepatitis: a clinicopathologic and follow-up study of 46 HBeAg-positiveasymptomatic patients. Am J Gastroenterol 1991, 86: 560-564.
CAS
PubMed
Google Scholar
Zarski JP, Marcellin P, Cohard M, et al.: Comparison of anti-HBe-positive and HBe-antigen-positive chronic hepatitis B in France. J Hepatol 1994, 20: 636-640. 10.1016/S0168-8278(05)80352-6
Article
CAS
PubMed
Google Scholar
Di Marco V, Lo Iacono O, Cammà C, et al.: The long-term course of chronic hepatitis B. Hepatology 1999, 30: 257-264. 10.1002/hep.510300109
Article
CAS
PubMed
Google Scholar
Chang MH, Hsu HY, Hsu HC, et al.: The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age. Hepatology 1995, 22: 1387-1392. 10.1016/0270-9139(95)90141-8
CAS
PubMed
Google Scholar
Bortolotti F, Jara P, Crivellaro C, et al.: Outcome of chronic hepatitis B in Caucasian children during a 20-year observation period. J Hepatol 1998, 29: 184-190. CDC. Hepatitis B virus: a comprehensive strategy for limiting transmission in the United States through universal child vaccination. Recommendation of the Immunization Practice Advisory Committee (ACIP). MMWR 1991;40:RR-13:1–25 10.1016/S0168-8278(98)80002-0
Article
CAS
PubMed
Google Scholar
Realdi G, Alberti A, Rugge M, et al.: Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology 1980, 79: 195-199.
CAS
PubMed
Google Scholar
Hoofnagle JH, Dusheiko GM, Seef LB, et al.: Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981, 94: 744-748.
Article
CAS
PubMed
Google Scholar
Fattovich G, Rugge M, Brollo L, et al.: Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B. Hepatology 1986, 6: 167-172.
Article
CAS
PubMed
Google Scholar
Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH: Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993, 18: 1313-1318. 10.1016/0270-9139(93)90217-B
Article
CAS
PubMed
Google Scholar
Yuen MF, Hui CK, Cheng CC, et al.: Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: the effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications. Hepatology 2001, 34: 139-145. 10.1053/jhep.2001.25273
Article
CAS
PubMed
Google Scholar
McMahon BJ, Holck P, Bulkow L, Snowball M: Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 2001, 135: 759-768.
Article
CAS
PubMed
Google Scholar
Bortolotti F, Cadrobbi P, Crivellaro C, et al.: Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood. Gastroenterology 1990, 99: 805-810.
CAS
PubMed
Google Scholar
Wong DKH, Cheung AM, O'Rourke K, et al.: Effect of alpha-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993, 119: 312-323.
Article
CAS
PubMed
Google Scholar
Vajro P, Migliaro F, Fontanella A, Orso G: Interferon: a meta-analysis of published studies in pediatric chronic hepatitis B. Acta Gastroenterol Belg 1998, 61: 219-223.
CAS
PubMed
Google Scholar
Chang MH, Sung JL, Lee CY, et al.: Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children. J Pediatr 1989, 115: 385-390.
Article
CAS
PubMed
Google Scholar
Lok ASF, Lai CL, Wu PC, Leung EKY, Lam TS: Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987, 92: 1839-1843.
CAS
PubMed
Google Scholar
Perillo RP: Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001, 120: 1009-1022.
Article
Google Scholar
Hadziyannis SJ, Vassilopoulos D: Hepatitis B e antigennegative chronic hepatitis B. Hepatology 2001, 34: 617-624. 10.1053/jhep.2001.27834
Article
CAS
PubMed
Google Scholar
Chan HLY, Leung NWY, Hussain M, Wong ML, Lok ASF: Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong. Hepatology 2000, 31: 763-768. 10.1002/hep.510310330
Article
CAS
PubMed
Google Scholar
Fattovich G, Farci P, Rugge M, et al.: Randomized controlled trial of lymphoblastoid interferon alfa in patients with chronic hepatitis B who lacked hepatitis B e antigen. Hepatology 1992, 15: 584-589.
Article
CAS
PubMed
Google Scholar
Lampertico P, Del Ninno E, Manzin A, et al.: A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum. Hepatology 1997, 26: 1621-1625.
Article
CAS
PubMed
Google Scholar
Tassopoulos NC, Volpes R, Pastore G, et al.: Efficacy of lamivudine in patients with hepatitis B e antigen negative hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Group. Hepatology 1999, 29: 889-896. 10.1002/hep.510290321
Article
CAS
PubMed
Google Scholar
Hsu YS, Chien RN, Yeh CT, et al.: Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002, 35: 1522-1527. 10.1053/jhep.2002.33638
Article
PubMed
Google Scholar
De Franchis R, Meucci G, Vecchi M, et al.: The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993, 118: 191-194.
Article
CAS
PubMed
Google Scholar
Bellentani S, Dal Molin G, Miglioli L, et al.: Natural history of HBV infection: a 9 years follow-up of the Dionysos cohort. J Hepatol 2002,36(Suppl 1):228. 10.1016/S0168-8278(02)80819-4
Article
Google Scholar
Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW: Long-term outcome of hepatitis B e antigen positive patients with compensated cirrhosis treated with interferon alfa. Hepatology 1997, 26: 1338-1342.
Article
CAS
PubMed
Google Scholar
Tassopoulos NC, Papaevangelou GJ, Sjogren MH, et al.: Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987, 92: 1844-1850.
CAS
PubMed
Google Scholar
Fattovich G, Giustina G, Sanchez-Tapias J, et al.: Delayed clearance of serum HBsAg in compensated cirrhosis B: relation to interferon alpha therapy and disease prognosis. Am J Gastroenterol 1998, 93: 896-900. 10.1111/j.1572-0241.1998.00272.x
Article
CAS
PubMed
Google Scholar
Huo TI, Wu JC, Lee PC, et al.: Sero-clearance of hepatitis B surface antigen in chronic carriers not necessarily implies a good prognosis. Hepatology 1998, 28: 231-236. 10.1002/hep.510280130
Article
CAS
PubMed
Google Scholar
Sarin Sk: Summary and recommendations of single theme conferences on hepatitis B and C: Indian association for study of the liver (INASL). J gastro hepatol 2002, 17: S197-S203. 10.1046/j.1440-1746.17.s3.1.x
Article
Google Scholar
Sarin SK, Sathpathy SK, Chauhan R: Hepatitis B e-antigen negative chronic hepatitis B. J gastro hepatol 2002, 17: S311-S321. 10.1046/j.1440-1746.17.s3.20.x
Article
Google Scholar
EASL international consensus conference on hepatitis B Journal of Hepatology 2003, 39: S3-S25.